Novartis: all 3,900 studies
Page 31 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed ConditionsCompletedNCT00913848Phase 1
- To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride TabletsCompletedNCT00913822Phase 1
- To Demonstrate the Relative Bioequivalency of Cord's 100 mg Desipramine HCL Tablets To Merrell Dow's 100 mg Norpramin TabletsCompletedNCT00913809Phase 1
- To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fasted ConditionsCompletedNCT00913783Phase 1
- To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fasting ConditionsCompletedNCT00913718Phase 1
- Safety/Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of LCZ696 in Patients With Stable Heart FailureCompletedNCT00913653Phase 2
- To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fed and Fasted ConditionsCompletedNCT00913588Phase 1
- To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg TabletsCompletedNCT00913549Phase 1
- To Demonstrate the Relative Bioavailability of Cyclobenzaprine HCl TabletsCompletedNCT00913419Phase 1
- To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 1 mgCompletedNCT00913341Phase 1
- To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride 50 mg TabletsCompletedNCT00913237Phase 1
- To Demonstrate the Relative Bioavailability of Diclofenac Sodium 50 mg Enteric-Coated TabletsCompletedNCT00913224Phase 1
- To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mgCompletedNCT00912145Phase 1
- A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 YearsCompletedNCT00909961Phase 3
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180CompletedNCT00907998Phase 1
- Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis BCompletedNCT00907894Phase 1
- Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic PhaseApproved for marketingNCT00905593
- A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)CompletedNCT00901979Phase 2
- Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart FailureCompletedNCT00894868Phase 4
- Efficacy and Safety of BGG492 in the Treatment of MigraineCompletedNCT00892203Phase 2
- Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease PatientsCompletedNCT00888004Phase 2
- Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy SurgeryCompletedNCT00887861Phase 2
- A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque PsoriasisCompletedNCT00885196Phase 2
- To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250 mg/5 ml Oral Suspension Fed ConditionsCompletedNCT00883883Phase 1
- To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablet Under Fasting and FedCompletedNCT00883506Phase 1
- To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting ConditionsCompletedNCT00883155Phase 1
- To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablets Under Fasting ConditionsCompletedNCT00883064Phase 1
- To Demonstrate the Relative Bioavailability of Metformin HCL 500 mg Extended Release (XR) Tablets Under Fasting ConditionsCompletedNCT00882882Phase 1
- To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicef 300 mg Capsule Fasting ConditionsCompletedNCT00882700Phase 1
- To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250mg/5 ml Oral Suspension Fasting ConditionsCompletedNCT00882570Phase 1
- To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 300 mg Capsule Fed ConditionsCompletedNCT00882154Phase 1
- To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed ConditionsCompletedNCT00881855Phase 1
- To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Fasting ConditionsCompletedNCT00881738Phase 1
- To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed ConditionsCompletedNCT00881634Phase 1
- To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting ConditionsCompletedNCT00881426Phase 1
- To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Fed ConditionsCompletedNCT00881400Phase 1
- To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting ConditionsCompletedNCT00881231Phase 1
- To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Non-Fasting ConditionsCompletedNCT00881179Phase 1
- To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions.CompletedNCT00881153Phase 1
- To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting ConditionsCompletedNCT00881127Phase 1
- Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid TumorsCompletedNCT00880308Phase 1
- A Study of HSP990 Administered by Mouth in Adult Patients With Advanced Solid TumorsCompletedNCT00879905Phase 1
- Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 MsecCompletedNCT00879242Phase 2
- Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis BCompletedNCT00877149Phase 4
- Comparative Bioavailability Study of Azithromycin 200mg/5mL Suspension Following a 600mg Dose Under Fed ConditionsCompletedNCT00875966Phase 1
- Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)WithdrawnNCT00869856Phase 3
- Comparative Bioavailability Study of 600mg Azithromycin Monohydrate Tablets Under Fasting ConditionsCompletedNCT00866216Phase 1
- To Demonstrate the Relative Bioavailability of Azithromycin 600 mg Tablets Under Fed ConditionsCompletedNCT00865670Phase 1
- Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed ConditionsCompletedNCT00865618Phase 1
- Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting ConditionsCompletedNCT00865176Phase 1
- A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting ConditionsCompletedNCT00865033Phase 1
- A Relative Bioavailability Study of Bupropion HCI 150 mg Sustained-Release Tablets Under Fasting ConditionsCompletedNCT00864981Phase 1
- Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting ConditionsCompletedNCT00864006Phase 1
- Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 WeeksWithdrawnNCT00862706Phase 4
- To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting ConditionsCompletedNCT00861939Phase 1
- Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 DiabetesCompletedNCT00860288Phase 2/3
- A Relative Bioavailability Study of 75mg Indomethacin Extended-Release CapsulesCompletedNCT00858195Phase 1
- Relative Bioavailability of a Fentanyl PatchCompletedNCT00857753Phase 1
- Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fasted ConditionsCompletedNCT00857428Phase 1
- Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed ConditionsCompletedNCT00857142Phase 1
- Study of EC0489 for the Treatment of Refractory or Metastatic TumorsCompletedNCT00852189Phase 1
- A Dose Ranging Study Comparing Different Combinations of Adjuvanted and Non-adjuvanted Influenza Vaccines in Healthy Children 6 to <36 Months of AgeCompletedNCT00848887Phase 1
- Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination SchedulesCompletedNCT00848029Phase 3
- Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDSTerminatedNCT00847678Phase 2
- Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular HypertensionCompletedNCT00846989Phase 1/2
- Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly SubjectsCompletedNCT00841646Phase 2
- Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular CarcinomaTerminatedNCT00828594Phase 1
- Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) PatientsCompletedNCT00826371Phase 3
- Pharmacodynamic/Pharmacokinetic Study of AQW051 in SchizophreniaCompletedNCT00825539Phase 1/2
- Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin MonotherapyCompletedNCT00822211Phase 3
- Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 DiabetesCompletedNCT00821977Phase 2/3
- Reducing the Overall Risk Level in Patients Suffering From Metabolic SyndromeCompletedNCT00821574Phase 4
- Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant RecipientsCompletedNCT00820911Phase 2
- Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired PatientsCompletedNCT00818571Phase 1/2
- Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma PatientsCompletedNCT00814216Phase 2
- Safety and Immunogenicity of a Monovalent Conjugated Vaccine Against Haemophilus Influenzae Type bCompletedNCT00808392Phase 3
- Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's PatientsCompletedNCT00795418Phase 2
- Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer AgentsCompletedNCT00790816Phase 1
- Phase II Study of TKI258 in Advanced Urothelial CarcinomaCompletedNCT00790426Phase 2
- A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast CancerCompletedNCT00788931Phase 1
- Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic PhaseCompletedNCT00786812Phase 4
- A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate AsthmaCompletedNCT00785083Phase 2
- A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure ChamberCompletedNCT00784732Phase 2
- Effect of BGG492 on EEG in Patients With Photosensitive EpilepsyCompletedNCT00784212Phase 2
- Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis BCompletedNCT00781105Phase 4
- Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)CompletedNCT00774020Phase 4
- Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)CompletedNCT00770081Phase 3
- Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)CompletedNCT00765830Phase 3
- Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C PatientsCompletedNCT00759200Phase 2
- Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) PatientsWithdrawnNCT00759083Phase 4
- A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone MetastasesTerminatedNCT00757757Phase 1/2
- Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia PatientsWithdrawnNCT00751608Phase 2
- A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on HemodialysisCompletedNCT00750295Phase 1/2
- Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2008/2009CompletedNCT00748813Phase 2
- Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009, When Administered to Non-Elderly Adult and Elderly SubjectsCompletedNCT00748150Phase 2
- Feasibility of Doctors' Rooms-based Infusion of Zoledronic AcidCompletedNCT00745485Phase 4
- Phase I Study to Determine the Maximum Tolerate Dose (MTD) of BGT226 in Advanced Solid Tumors in JapanTerminatedNCT00742105Phase 1
- A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma PatientsCompletedNCT00741377Phase 1
- Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid TumorsCompletedNCT00739414Phase 1
- A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung CancerTerminatedNCT00738387Phase 3